Prolyl hydroxylase domain inhibitors: a new era in the management of renal anemia.

ABSTRACT:

SUBMITTER: Kurata Y 

PROVIDER: S-EPMC6976456 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature